The 315 was for the AGENDA trial that FAILED. That is the results they are going to release at ASCO.
The number you are interested is the number that was in the sub-group that they noticed the OS was higher. I think it was the low-medium ldh group. That is just a small segment of the AGENDA trial.
Really people, if you don't understand this stuff you should not be investing here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.